Article Details

Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug

Retrieved on: 2022-12-09 15:22:32

Tags for this article:

Click the tags to see associated articles and topics

Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug. View article details on hiswai:

Excerpt

The companies forged a multi-year partnership in 2018 to develop blood-based companion diagnostic tests for drugs in AstraZeneca's oncology ...

Article found on: www.360dx.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up